株式会社Veritas In Silico Logo

株式会社Veritas In Silico

An in silico drug discovery platform creating mRNA-targeting medicines with pharma partners.

130A | T

Overview

Corporate Details

ISIN(s):
JP3155340007
LEI:
Country:
Japan
Address:
品川区西五反田一丁目11番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Veritas In Silico Inc. is a drug discovery platform company specializing in the creation of small molecule and nucleic acid medicines that target messenger RNA (mRNA). The company utilizes its proprietary *in silico* (computational simulation) technologies, combining quantum chemistry calculations with robust high-throughput screening, to design novel therapeutics for previously undruggable targets. Its core business involves establishing joint research and development partnerships with major pharmaceutical companies, earning revenue through milestone payments and future royalties. Veritas In Silico has secured numerous collaborations with leading firms such as Takeda, Shionogi, and Mitsubishi Gas Chemical. The company was listed on the Tokyo Stock Exchange Growth Market in February 2024.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:00
Interim Report
半期報告書-第10期(2025/01/01-2025/12/31)
Japanese 177.7 KB
2025-08-14 08:00
Interim Report
確認書
Japanese 8.8 KB
2025-03-28 05:18
Post-Annual General Meeting Information
臨時報告書
Japanese 27.1 KB
2025-03-28 02:47
Regulatory News Service
内部統制報告書-第9期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-28 02:47
Regulatory News Service
確認書
Japanese 8.8 KB
2025-03-28 02:46
Annual Report
有価証券報告書-第9期(2024/01/01-2024/12/31)
Japanese 3.1 MB
2024-08-14 08:00
Interim Report
確認書
Japanese 8.7 KB
2024-08-14 08:00
Interim Report
半期報告書-第9期(2024/01/01-2024/12/31)
Japanese 171.1 KB
2024-05-15 09:55
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-15 08:00
Quarterly Report
四半期報告書-第9期第1四半期(2024/01/01-2024/03/31)
Japanese 146.8 KB
2024-03-15 07:01
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2024-03-15 07:00
Annual Report
有価証券報告書-第8期(2023/01/01-2023/12/31)
Japanese 3.1 MB
2024-02-08 01:05
Major Shareholding Notification
臨時報告書
Japanese 21.1 KB
2024-01-31 07:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-01-23 07:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB

Automate Your Workflow. Get a real-time feed of all 株式会社Veritas In Silico filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社Veritas In Silico

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社Veritas In Silico via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan
4196
Neonode Inc. Logo
Licenses optical sensing and computer vision for HMI in automotive and consumer electronics.
United States of America
NEON
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France
ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia
NFM
NexGen Energy Ltd. Logo
Uranium exploration company developing a high-grade mine to supply global clean energy fuel.
United States of America
NXE
Nexxen International Ltd. Logo
End-to-end programmatic ad platform for advertisers, agencies, & publishers, specializing in video & CTV.
United States of America
NEXN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France
ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden
NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan
2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan
4893

Talk to a Data Expert

Have a question? We'll get back to you promptly.